Medical Condition News

RSS

New personalized therapy fools cancer cells into killing themselves

A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves.

1 Mar 2011

'Tea and Toast Syndrome' leads to loss of wellness and muscle in seniors

Elderly people who live on their own that don't prepare whole meals or don't know how tend to dwindle their intake to "tea and toast" at the expense of vital nutrients and their health, according to an article published in the February issue of Food Nutrition & Science.

1 Mar 2011

Uterine fibroid treatments greatly improve quality of life in women

Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to a new study published in the May issue of Radiology.

1 Mar 2011

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30- or 60-minute application. The new treatment patch uses capsaicin - the substance found in chilli peppers which gives them their 'heat' - to change the function of pain sensing nerves in the area of skin affected.

1 Mar 2011

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.

1 Mar 2011

Depression negatively impacts outcomes of care in patients with CRS: New research

Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2011

HCI creates Pediatric Cancer Late Effects Clinic to help manage long-term issues of treatment

Although cancer in children is rare, more than 10,000 children in the United States are diagnosed with some form of the disease every year. If these children survive, studies have found that more than two-thirds develop at least one late-effect of treatment, which can include additional cancers, fertility and heart problems, limited limb function, and hearing loss.

1 Mar 2011

Aggressive treatment of T3 and T4 NSCLC with induction chemoradiotherapy may improve survival

Researchers from Boston University School of Medicine (BUSM) have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. These findings currently appear on-line in the Journal of Thoracic and Cardiovascular Surgery.

1 Mar 2011

Brain's reward/motivation circuits linked to compulsive overeating

A brain imaging study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory reveals a subtle difference between ordinary obese subjects and those who compulsively overeat, or binge: In binge eaters but not ordinary obese subjects, the mere sight or smell of favorite foods triggers a spike in dopamine - a brain chemical linked to reward and motivation.

1 Mar 2011

Dermatan sulfate holds potential as an additional biomarker for Sanfilippo disease

Sanfilippo disease is a rare disorder caused by the failure of enzymes to break down specific kinds of complex carbohydrates, resulting in their accumulation in cells and often severe physical and neurological problems - and sometimes early death.

1 Mar 2011

Researchers combine old bones and new technology to treat chronic back pain

The bones of people who died up to a hundred years ago are being used in the development of new treatments for chronic back pain. It is the first time old bones have been used in this way.

1 Mar 2011

Despite absence of Medicare coverage, hospital use of CTC is on the rise: Study

Despite the absence of Medicare coverage, hospital use of computed tomographic colonography, commonly referred to as virtual colonoscopy, is on the rise, according to a study in the March issue of the Journal of the American College of Radiology.

1 Mar 2011

HP announces innovative drug research application for its inkjet technology

HP today announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.

1 Mar 2011

Protein pathway may hold a clue for understanding Parkinson's disease

A protein pathway that may hold the secret to understanding Parkinson's disease has been discovered and explained by Iowa State University researchers.

1 Mar 2011

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals for the development of an active vaccination programme against Alzheimer's disease.

1 Mar 2011

Researcher identifies substance that inhibits cancer growth by activating 'dark genome'

A research study coordinated by Manel Esteller, researcher at Bellvitge Biomedical Research Institute (IDIBELL) has identified a substance that inhibits cancer growth by activating the so‑called "dark genome" (or non‑coding DNA) and micro‑RNA molecules. The study appears this week in the journal Proceedings of the National Academy of Sciences (PNAS).

1 Mar 2011

Cancer drug may help combat flu

Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.

1 Mar 2011

New study: Lifestyle intervention can help pregnant women control their weight

Excessive weight gain isn't healthy at any stage of life, but during pregnancy it can do lasting harm to the mother and baby alike. Now researchers at Brown University and The Miriam Hospital are encouraged by a new study describing an intervention that helped pregnant women control their weight.

1 Mar 2011

Nile plans to develop novel therapeutics for ADHF

Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, announced plans to pursue a new indication in the field of heart failure.

1 Mar 2011

Two genes linked to binge drinking

University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.

1 Mar 2011

Medical Condition News

New personalized therapy fools cancer cells into killing themselves

'Tea and Toast Syndrome' leads to loss of wellness and muscle in seniors

Uterine fibroid treatments greatly improve quality of life in women

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

Depression negatively impacts outcomes of care in patients with CRS: New research

HCI creates Pediatric Cancer Late Effects Clinic to help manage long-term issues of treatment

Aggressive treatment of T3 and T4 NSCLC with induction chemoradiotherapy may improve survival

Brain's reward/motivation circuits linked to compulsive overeating

Dermatan sulfate holds potential as an additional biomarker for Sanfilippo disease

Researchers combine old bones and new technology to treat chronic back pain

Despite absence of Medicare coverage, hospital use of CTC is on the rise: Study

HP announces innovative drug research application for its inkjet technology

Protein pathway may hold a clue for understanding Parkinson's disease

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

Researcher identifies substance that inhibits cancer growth by activating 'dark genome'

Cancer drug may help combat flu

New study: Lifestyle intervention can help pregnant women control their weight

Nile plans to develop novel therapeutics for ADHF

Two genes linked to binge drinking

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Latest News